202 related articles for article (PubMed ID: 22461510)
21. FAIMS and Phosphoproteomics of Fibroblast Growth Factor Signaling: Enhanced Identification of Multiply Phosphorylated Peptides.
Zhao H; Cunningham DL; Creese AJ; Heath JK; Cooper HJ
J Proteome Res; 2015 Dec; 14(12):5077-87. PubMed ID: 26503514
[TBL] [Abstract][Full Text] [Related]
22. Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters.
Abe Y; Nagano M; Tada A; Adachi J; Tomonaga T
J Proteome Res; 2017 Feb; 16(2):1077-1086. PubMed ID: 28152594
[TBL] [Abstract][Full Text] [Related]
23. Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells.
Thelemann A; Petti F; Griffin G; Iwata K; Hunt T; Settinari T; Fenyo D; Gibson N; Haley JD
Mol Cell Proteomics; 2005 Apr; 4(4):356-76. PubMed ID: 15657067
[TBL] [Abstract][Full Text] [Related]
24. Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling.
Amanchy R; Zhong J; Hong R; Kim JH; Gucek M; Cole RN; Molina H; Pandey A
Mol Oncol; 2009 Dec; 3(5-6):439-50. PubMed ID: 19632164
[TBL] [Abstract][Full Text] [Related]
25. Reconstitution of the B cell antigen receptor signaling components in COS cells.
Saouaf SJ; Kut SA; Fargnoli J; Rowley RB; Bolen JB; Mahajan S
J Biol Chem; 1995 Nov; 270(45):27072-8. PubMed ID: 7592958
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- and receptor-tyrosine kinases.
Sommer U; Schmid C; Sobota RM; Lehmann U; Stevenson NJ; Johnston JA; Schaper F; Heinrich PC; Haan S
J Biol Chem; 2005 Sep; 280(36):31478-88. PubMed ID: 16000307
[TBL] [Abstract][Full Text] [Related]
27. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.
Rush J; Moritz A; Lee KA; Guo A; Goss VL; Spek EJ; Zhang H; Zha XM; Polakiewicz RD; Comb MJ
Nat Biotechnol; 2005 Jan; 23(1):94-101. PubMed ID: 15592455
[TBL] [Abstract][Full Text] [Related]
28. The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors.
Rivard N; McKenzie FR; Brondello JM; Pouysségur J
J Biol Chem; 1995 May; 270(18):11017-24. PubMed ID: 7537742
[TBL] [Abstract][Full Text] [Related]
29. Pleckstrin homology and phosphotyrosine-binding domain-dependent membrane association and tyrosine phosphorylation of Dok-4, an inhibitory adapter molecule expressed in epithelial cells.
Bedirian A; Baldwin C; Abe J; Takano T; Lemay S
J Biol Chem; 2004 Apr; 279(18):19335-49. PubMed ID: 14963042
[TBL] [Abstract][Full Text] [Related]
30. Identification of residues in the beta platelet-derived growth factor receptor that confer specificity for binding to phospholipase C-gamma 1.
Larose L; Gish G; Shoelson S; Pawson T
Oncogene; 1993 Sep; 8(9):2493-9. PubMed ID: 7689724
[TBL] [Abstract][Full Text] [Related]
31. High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcoma.
Crompton BD; Carlton AL; Thorner AR; Christie AL; Du J; Calicchio ML; Rivera MN; Fleming MD; Kohl NE; Kung AL; Stegmaier K
Cancer Res; 2013 May; 73(9):2873-83. PubMed ID: 23536552
[TBL] [Abstract][Full Text] [Related]
32. Preclinical Evaluation of Nintedanib, a Triple Angiokinase Inhibitor, in Soft-tissue Sarcoma: Potential Therapeutic Implication for Synovial Sarcoma.
Patwardhan PP; Musi E; Schwartz GK
Mol Cancer Ther; 2018 Nov; 17(11):2329-2340. PubMed ID: 30166401
[TBL] [Abstract][Full Text] [Related]
33. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein.
Faris M; Gaskin F; Parsons JT; Fu SM
J Exp Med; 1994 Jun; 179(6):1923-31. PubMed ID: 7515102
[TBL] [Abstract][Full Text] [Related]
34. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
35. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
[TBL] [Abstract][Full Text] [Related]
36. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
[TBL] [Abstract][Full Text] [Related]
37. Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.
Thomson S; Petti F; Sujka-Kwok I; Epstein D; Haley JD
Clin Exp Metastasis; 2008; 25(8):843-54. PubMed ID: 18696232
[TBL] [Abstract][Full Text] [Related]
38. Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors.
Pandey A; Podtelejnikov AV; Blagoev B; Bustelo XR; Mann M; Lodish HF
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):179-84. PubMed ID: 10618391
[TBL] [Abstract][Full Text] [Related]
39. Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors.
Alonso G; Koegl M; Mazurenko N; Courtneidge SA
J Biol Chem; 1995 Apr; 270(17):9840-8. PubMed ID: 7730365
[TBL] [Abstract][Full Text] [Related]
40. Correlations between the expression, phosphotyrosine content and enzymatic activity of focal adhesion kinase, pp125FAK, in tumor and nontransformed cells.
Withers BE; Hanks SK; Fry DW
Cancer Biochem Biophys; 1996 Apr; 15(3):127-39. PubMed ID: 8937737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
